Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
43.7M
-
Shares change
-
-1.26M
-
Total reported value, excl. options
-
$185M
-
Value change
-
-$6.83M
-
Put/Call ratio
-
0.82
-
Number of buys
-
60
-
Number of sells
-
-52
-
Price
-
$4.25
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q2 2023
146 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q2 2023.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.7M shares
of 92.2M outstanding shares and own 47.38% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (5.57M shares), BlackRock Inc. (4.76M shares), Avidity Partners Management LP (2.76M shares), BANK OF AMERICA CORP /DE/ (2.75M shares), Rokos Capital Management LLP (2.75M shares), VANGUARD GROUP INC (2.56M shares), Elmwood Wealth Management, Inc. (2.36M shares), PICTET ASSET MANAGEMENT SA (1.81M shares), FMR LLC (1.44M shares), and ALKEON CAPITAL MANAGEMENT LLC (1.36M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.